Skip to content

Clinical trials

Terminated Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Terminated Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20062
20071
20092
20113
20141
20151
20164
20182
20194
20216

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eloxx Pharmaceuticals, Inc.2
HemoShear Therapeutics2
National Center for Research Resources (NCRR)2
Novartis Pharmaceuticals2
BioMarin Pharmaceutical1
Centre Hospitalier Universitaire, Amiens1
Children's Hospital Los Angeles1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Fairview University Medical Center1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn32
Metabolic Diseases7
Metabolism, Inborn Errors5
Rare Diseases5
Hematologic Diseases3
Muscular Dystrophy, Duchenne3
Musculoskeletal Diseases3
Nervous System Diseases3
Anemia, Aplastic2
Blood Coagulation Disorders2

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.